Companies › SRPT

SAREPTA THERAPEUTICS INC (SRPT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000873303 · EDGAR filings · Updated 2026-07-28

SAREPTA THERAPEUTICS INC (SRPT) has reported institutional ownership of 97.4%, with 339 institutional managers holding positions valued at $2.23B per the latest 13F reporting period.

Filings this week (2)

• 2026-07-28 — Employee-plan registration (S-8) filed
• 2026-07-27 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-05 — Insider transaction reported (Form 4)
• 2026-06-05 — Insider transaction reported (Form 4)
• 2026-06-05 — Insider transaction reported (Form 4)
• 2026-06-05 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, SAREPTA THERAPEUTICS INC has 339 institutional holders and institutional ownership of 97.4%.

Insider activity

Insiders reported 49 transactions (0 buys, 2 sells) across 9 reporting insiders, with a net reported value of −$417.4K.

Related companies

WARBY PARKER INC CL A COM (WRBY) · SUMMIT THERAPEUTICS INC (SMMT) · GENMAB A/S (GMAB) · VIRIDIAN THERAPEUTICS INC (VRDN) · KODIAK SCIENCES (KOD) · ALUMIS INC (ALMS)